Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data
Maria Paula Diaz Soto,1 Joseph K Lim2 1Department of Medicine, Yale School of Medicine, New Haven, CT, USA; 2Yale Liver Center and Section of Digestive Diseases, Yale School of Medicine, New Haven, CT, USACorrespondence: Joseph K LimProfessor of Medicine, Yale Liver Center and Section of Digestive D...
Saved in:
Main Authors: | Diaz Soto MP, Lim JK |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/4cb2a65da7ce4a4da3a22e9ab8eb02c3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Autophagy: a new target for nonalcoholic fatty liver disease therapy
by: Mao YQ, et al.
Published: (2016) -
Obesity and nonalcoholic fatty liver disease: current perspectives
by: Sarwar R, et al.
Published: (2018) -
Effect of sitagliptin on hepatic histological activity and fibrosis of nonalcoholic steatohepatitis patients: a 1-year randomized control trial
by: Alam S, et al.
Published: (2018) -
Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
by: Lauszus JS, et al.
Published: (2021) -
Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis
by: Shahinul Alam, et al.
Published: (2021)